Shoulder Innovations, Inc. (SI) |
| 19.13 -1.31 (-6.41%) 10-30 16:00 |
| Open: | 20.5 |
| High: | 20.74 |
| Low: | 19.06 |
| Volume: | 118,950 |
| Market Cap: | 398(M) |
| PE Ratio: | -11.06 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Specialties |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 24.22 |
| Resistance 1: | 20.74 |
| Pivot price: | 18.94 |
| Support 1: | 18.16 |
| Support 2: | 16.56 |
| 52w High: | 24.6 |
| 52w Low: | 10.92 |
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 23 Oct 2026
Shoulder Innovations, Inc. Estimates – NYSE:SI - TradingView
Thu, 15 Oct 2026
Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026 - Yahoo Finance
Thu, 08 Oct 2026
A new shoulder implant was used in its first operation. Its design cuts surgical steps. - Stock Titan
Thu, 08 Oct 2026
Shoulder Innovations Initiates Commercial Launch of the InSet® Go - Orthopedics This Week
Thu, 10 Sep 2026
Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch - Ortho Spine News
Wed, 09 Sep 2026
Shoulder Innovations partners with ALM Ortho on implants - Investing.com
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
